After Consent Decree, Wockhardt May Sell US Site Amid Wider Revamp

 
• By Anju Ghangurde

Wockhardt’s US arm Morton Grove Pharmaceuticals, which is bound by a consent decree of permanent injunction, discontinues production to undertake an “orderly closure” and potential sale of its Illinois site. Indian parent firm taps contract manufacturers to service US market.

Wockhardt's US arm discontinues operations at Illinois site • Source: Shutterstock

More from Manufacturing

More from Business